AI assistant
Borregaard — Regulatory Filings 2014
Oct 22, 2014
3562_iss_2014-10-22_f892b73e-1dee-4b2d-a381-157fdd021bc9.html
Regulatory Filings
Open in viewerOpens in your device viewer
Borregaard: Investing NOK 225 million in a production facility for Exilva microfibrillar cellulose
Borregaard: Investing NOK 225 million in a production facility for Exilva microfibrillar cellulose
(22 October 2014) Borregaard ASA ("Borregaard", OSE ticker: BRG)
Borregaard's Board of Directors has decided to invest in a facility for the
production of Exilva microfibrillar cellulose (MFC). The plant will be built at
the Borregaard site in Sarpsborg. The investment is estimated to NOK 225
million.
The project is based on new innovations related to the product itself as well as
to the production process and the applications. Exilva MFC is based on natural
and renewable raw materials. It has the potential to replace products derived
from petrochemicals, and it also represents an opportunity to exchange organic
solvent systems with water based solutions. In total this will lead to
considerable positive environmental effects.
Borregaard's project to develop MFC started in 2005, and the R&D work has partly
been carried out in a pilot plant. The development work has taken place in close
cooperation with potential customers. The raw material, specialty cellulose, is
split into a complex network of fibrils with the use of proprietary technology
developed as part of the project. Exilva MFC has a unique set of
characteristics, including rheology modification, stabilisation, texture
modification and water retention. It can therefore find its way into valuable
and novel applications in a variety of products such as adhesives, detergents,
cosmetics, composites and other industrial formulations.
The commercial scale facility will have an initial design capacity of 1000
tonnes per year with a potential for expansion. Production is expected to start
in the 3rd quarter of 2016.
"Borregaard is well positioned to develop microfibrillar cellulose. The company
has a broad experience in the production of bio-chemicals based on natural raw
materials, a strong competence base within R&D for specialty products, and a
global marketing organisation directed towards customers in the chemical
industry. If successful, this project has the potential to become a new and
exciting business area for Borregaard", says President and CEO Per A. Sørlie.
Contact:
Jørn Syvertsen, Director Investor Relations, mobile +47 9583 6335
This information is subject to the disclosure requirements pursuant to Section
5-12 of the Norwegian Securities Trading Act.
[HUG#1864603]